Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Accured Expenses (2021 - 2026)

bioAffinity Technologies has reported Change in Accured Expenses over the past 5 years, most recently at $310857.0 for Q1 2026.

  • Quarterly Change in Accured Expenses rose 1210.72% to $310857.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $658111.0 through Mar 2026, up 35.02% year-over-year, with the annual reading at $319267.0 for FY2025, 28.27% up from the prior year.
  • Change in Accured Expenses was $310857.0 for Q1 2026 at bioAffinity Technologies, down from $733442.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $733442.0 in Q4 2025 and troughed at -$399318.0 in Q4 2022.
  • The 5-year median for Change in Accured Expenses is -$27987.0 (2025), against an average of $76904.8.
  • Year-over-year, Change in Accured Expenses tumbled 476.22% in 2025 and then surged 1210.72% in 2026.
  • A 5-year view of Change in Accured Expenses shows it stood at -$399318.0 in 2022, then skyrocketed by 226.72% to $506025.0 in 2023, then fell by 2.28% to $494470.0 in 2024, then soared by 48.33% to $733442.0 in 2025, then crashed by 57.62% to $310857.0 in 2026.
  • Per Business Quant, the three most recent readings for BIAF's Change in Accured Expenses are $310857.0 (Q1 2026), $733442.0 (Q4 2025), and -$63487.0 (Q3 2025).